GOLD, L. S.; LEBWOHL, M. G.; BHATIA, N.; LIN, T.; PILLAI, R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S31, 2019. DOI: 10.25251/skin.3.supp.31. Disponível em: https://www.jofskin.org/index.php/skin/article/view/758. Acesso em: 16 may. 2022.